Command Palette

Search for a command to run...

Clinical Trials · NCT07280221

WEgovy Real World Assessment of Weight Loss in Korea

Enrolling By InvitationN/ASemaglutide (Investigational)
Phase
N/A
Recruitment status
Enrolling By Invitation
Sponsor
Novo Nordisk A/S
Enrollment
500
Start date
Nov 2025
Locations
1 site, South Korea
Primary endpoint
Percentage change in body weight
View Semaglutide compound reference